fluorodeoxyglucose f18 has been researched along with Heart Diseases in 80 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.25) | 18.7374 |
| 1990's | 13 (16.25) | 18.2507 |
| 2000's | 14 (17.50) | 29.6817 |
| 2010's | 34 (42.50) | 24.3611 |
| 2020's | 18 (22.50) | 2.80 |
| Authors | Studies |
|---|---|
| Freeburg, LA; Herzog, E; Miller, EJ; Moreland, H; Oatmen, KE; Shahab, Z; Spinale, FG; Young, BD | 1 |
| AlShaheen, M; Chow, B; Leung, E; Mistry, NP; Wiefels, C | 1 |
| Antoni, D; Eber, J; Leroy-Freschini, B; Noël, G; Pflumio, C | 1 |
| Ahmed, AI; Al Rifai, M; Al-Mallah, MH; Alahdab, F; Alfawara, MS; Alnabelsi, T; Han, Y; Kassi, M; Saad, JM; Zoghbi, WA | 1 |
| Granziera, F; Guzzardi, MA; Iozzo, P; Kusmic, C; La Rosa, F; Panetta, D; Terlizzi, D | 1 |
| Conte, M; Corica, F; De Feo, MS; De Vincentis, G; Filippi, L; Frantellizzi, V; Gorica, J; Schillaci, O; Sidrak, MMA | 1 |
| Ambrosioni, J; Bosch, J; Cuervo, G; Dahl, A; Falces, C; Fuster, D; Hernández-Meneses, M; Llopis, J; Marco, F; Miró, JM; Moreno, A; Páez-Martínez, S; Perissinotti, A; Sandoval, E; Tolosana, JM; Vidal, B | 1 |
| Aikawa, T; Anzai, T; Furuya, S; Koyanagawa, K; Kuzume, M; Manabe, O; Naya, M; Ohira, H; Oyama-Manabe, N; Tsujino, I | 1 |
| Benetos, G; Giannopoulos, AA | 1 |
| Bhambhvani, P; Hage, FG; Iskandrian, AE | 1 |
| Fujimoto, K; Mitamura, K; Nishiyama, Y; Norikane, T; Takami, Y; Yamamoto, Y | 1 |
| Kim, SH; Kim, SJ; Kim, YS | 1 |
| Minamimoto, R | 1 |
| Chen, X; Lin, K; Miao, W; Xue, Q; Yao, S | 1 |
| Belperio, JA; Bradfield, JS; Lynch, JP; Moriarty, JM; Sayah, DM | 1 |
| Aikawa, T; Hirata, K; Katoh, C; Kroenke, M; Manabe, O; Masuda, A; Murayama, A; Naya, M; Oyama-Manabe, N; Shiga, T; Tamaki, N; Watanabe, S | 1 |
| Better, N; Jayadeva, PS | 1 |
| Atterton-Evans, V; Robertson, T; Turner, J; Vivanti, A | 1 |
| Boutley, H; Clément, A; Karcher, G; Kolodziej, A; Lhuillier, M; Marie, PY; Maskali, F; Olivier, JL; Pierson, J; Poussier, S | 1 |
| Liu, Y | 1 |
| Chen, X; Higuchi, T; Javadi, MS; Lapa, C; Rowe, SP; Werner, RA | 1 |
| Das, JP; Ginsberg, MS; Halpenny, DF; Hayes, SA; Riedl, CC; Xie, L | 1 |
| Hara, H; Ito, K; Kubota, K; Minamimoto, R; Miyata, Y; Moroi, M; Morooka, M; Okasaki, M; Okazaki, O | 1 |
| Butler, J; Prato, FS; Rajchl, M; Thompson, RT; White, JA; Wisenberg, G | 1 |
| Ishibashi, K; Takeda, M; Yamahara, Y | 1 |
| Bertagna, F; Treglia, G | 1 |
| Erba, PA; Lazzeri, E; Mariani, G; Sollini, M | 1 |
| Erba, PA; Iung, B; Lazzeri, E; Petrosillo, N | 1 |
| Bengel, FM; Schatka, I | 1 |
| Egashira, T; Fujita, J; Fukuda, K; Inohara, T | 1 |
| Higaki, J; Miyagawa, M; Mochizuki, T; Nishiyama, Y; Ogimoto, A; Yokoyama, R | 1 |
| Ahmadian, A; Berman, J; Brogan, A; Govender, P; Mazzini, M; Mercier, G; Miller, EJ; Ruberg, FL; Sverdlov, AL | 1 |
| Blankstein, R; Waller, AH | 1 |
| Bradfield, J; Fishbein, M; Hwang, J; Lynch, JP; Shivkumar, K; Tung, R | 1 |
| Gerbaudo, VH; Wachsmann, JW | 1 |
| Magota, K; Manabe, O; Masuda, A; Naya, M; Tamaki, N; Tsutsui, H; Yoshinaga, K | 1 |
| Blankstein, R; Miller, EJ | 1 |
| Álvarez Moro, FJ; García, JR; Sánchez, R | 1 |
| Doruyter, A; Sathekge, M; Vorster, M; Warwick, JM | 1 |
| Chenard, MP; Dégot, T; El Ghannudi, S; Germain, P; Herbrecht, R; Imperiale, A; Kessler, R; Le Van Quyen, P; Letscher-Bru, V; Petean, R; Trinh, A | 1 |
| Faggian, G; Fejzo, M; Rampin, L; Rinuncini, M; Roncon, L; Rubello, D; Scaranello, F; Zuin, M | 1 |
| Baxa, J; Ferda, J; Hromádka, M | 1 |
| Kotzerke, J; Zöphel, K | 1 |
| Hara, H; Nonaka, A; Shimada, T; Shiotani, H; Stugaard, M; Ueda, O | 1 |
| Patterson, GA; Peterson, LR; Rao, PM; Woodard, PK | 1 |
| Abraham, A; Beanlands, RS; Dasilva, J; Dekemp, RA; Garrard, L; Gollob, MH; Green, MS; Ha, AC; Renaud, JM; Thorn, S; Yoshinaga, K | 1 |
| Kajander, S; Knuuti, J; Saraste, A; Ukkonen, H | 1 |
| Koiwa, H; Nishimura, M; Ohira, H; Otsuka, N; Tsujino, I; Yoshinaga, K | 1 |
| Bergmann, SR; Giedd, KN | 1 |
| Adler, LP; Burshteyn, M; Gaughan, JP; Maurer, AH; Steiner, RM | 1 |
| Grant, FD; Treves, ST | 1 |
| Cohen, P; Duboc, D; Guillevin, L; Guilpain, P; Legmann, P; Marmursztejn, J; Mouthon, L; Pagnoux, C; Trebossen, R; Vignaux, O | 1 |
| Chen, JY; Feng, Y; Guo, XM; Hu, SL; Hu, WG; Orecchia, R; Pan, ZQ; Shao, ZM; Wang, JZ; Yu, XL; Zhang, Q; Zhang, YJ; Zhang, Z | 1 |
| Brown, RK; Corbett, JR; Dvorak, RA; Kazerooni, EA; Lobert, P; Wong, KK | 1 |
| Dilsizian, V; Taillefer, R | 1 |
| Okauchi, K; Tokue, A; Tokue, H; Tsushima, Y | 1 |
| Aldighieri, F; Alonso, G; Duarte, PS; Machado, C; Martins, LR; Zhuang, H | 1 |
| Keng, FY | 1 |
| Cuocolo, A | 1 |
| Bax, JJ | 1 |
| Fukuchi, K; Ishida, Y; Matsumura, K; Ohta, H | 1 |
| Tamaki, N; Yoshinaga, K | 1 |
| Bar-Shalev, A; Bar-Shalom, R; Frenkel, A; Israel, O; Keidar, Z; Rispler, S; Strauss, HW; Weiler-Sagie, M | 1 |
| Brambilla, M; Gandolfo, P; Inglese, E; Leva, L; Matheoud, R; Sacchetti, G; Sambuceti, G; Secco, C | 1 |
| Fukushi, K; Himi, T; Irie, T; Iyo, M; Masuda, Y; Nakagawa, K; Namba, H; Shikama, N; Yamanouchi, M; Yoshida, K | 1 |
| Cook, SA; Fix, JS; Go, RT; James, KB; Lee, KS; MacIntyre, WJ; Marwick, TH; Sapp, SK; Thomas, JD | 1 |
| Cerqueira, MD; Itchhaporia, D | 1 |
| Kinoshita, S; Serizawa, T | 1 |
| Beanlands, R | 1 |
| Bøtker, HE; Bøttcher, M; Gjedde, A; Nielsen, TT | 1 |
| Fukuchi, K; Hasimoto, N; Ishida, Y; Miyake, Y; Oka, M; Sagoh, M | 1 |
| Boxt, LM; Fawwaz, R; Plutchok, JJ; Sherman, WH; Van Heertum, RL; Weinberger, J | 1 |
| Bax, JJ; Groenveld, AB; Huitink, JM; Teule, GJ; van Lingen, A; Visser, CA; Visser, FC | 1 |
| Wagner, HN | 1 |
| Adam, D; Gorschlüter, P; Kuwert, T; Lottes, G; Schober, O | 1 |
| Fukuchi, K; Hasegawa, S; Kobayashi, T; Matsuzawa, Y; Nakagawa, T; Nishimura, T; Nozaki, S; Tomiyama, Y; Uehara, T; Yamashita, S; Yoshizumi, T | 1 |
| Bax, JJ; Elhendy, A; Patton, JA; Poldermans, D; Sandler, MP | 1 |
| Visser, FC | 1 |
| Arimizu, N; Himi, T; Imazeki, K; Inagaki, Y; Ito, Y; Kagaya, A; Masuda, Y; Niwayama, H; Uematsu, S; Yoshida, K | 1 |
| Maurer, AH | 1 |
29 review(s) available for fluorodeoxyglucose f18 and Heart Diseases
| Article | Year |
|---|---|
Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics-Where We Are at and Where We Are Heading: A Systematic Review.
Topics: Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Heart Diseases; Humans; Positron Emission Tomography Computed Tomography; Precision Medicine; PubMed; Sample Size | 2023 |
A quick glance at selected topics in this issue.
Topics: Cardiology; Cardiovascular Diseases; Endocarditis; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Myocardial Perfusion Imaging; Nuclear Medicine; Peer Review; Positron-Emission Tomography; Societies, Medical; Technetium; Tomography, Emission-Computed, Single-Photon; United States | 2020 |
Diagnostic performance of PET for detection of cardiac amyloidosis: A systematic review and meta-analysis.
Topics: Amyloidosis; Fluorodeoxyglucose F18; Heart Diseases; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sodium Fluoride | 2020 |
Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT.
Topics: Fasting; Female; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Male; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Cardiac Involvement in Sarcoidosis: Evolving Concepts in Diagnosis and Treatment.
Topics: Fluorodeoxyglucose F18; Glucocorticoids; Heart Diseases; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Sarcoidosis; Tomography, X-Ray Computed | 2017 |
Variances of dietary preparation for suppression of physiological
Topics: Animals; Australia; Calcium Channel Blockers; Diet; Fluorodeoxyglucose F18; Heart; Heart Diseases; Heparin; Humans; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2020 |
Recent paradigm shifts in molecular cardiac imaging-Establishing precision cardiology through novel
Topics: Animals; Cardiology; Coronary Circulation; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Inflammation Mediators; Molecular Imaging; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Tissue Survival | 2020 |
Cardiothoracic manifestations of Erdheim-Chester disease.
Topics: Contrast Media; Erdheim-Chester Disease; Fluorodeoxyglucose F18; Heart Diseases; Humans; Lung Diseases; Magnetic Resonance Imaging; Mediastinal Diseases; Multimodal Imaging; Pleural Diseases; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2019 |
FDG-PET in cardiac infections.
Topics: Fluorodeoxyglucose F18; Heart Diseases; Humans; Infections; Positron-Emission Tomography | 2013 |
Common diagnostic flowcharts in infective endocarditis.
Topics: Decision Support Systems, Clinical; Echocardiography, Transesophageal; Endocarditis, Bacterial; Endocardium; False Positive Reactions; Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Male; Neoplasm Metastasis; Polymerase Chain Reaction; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Advanced imaging of cardiac sarcoidosis.
Topics: Cardiomyopathies; Clinical Trials as Topic; Fluorodeoxyglucose F18; Heart Diseases; Humans; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2014 |
Positron emission tomography-computed tomography for imaging of inflammatory cardiovascular diseases.
Topics: Animals; Arteritis; Atherosclerosis; Fluorodeoxyglucose F18; Heart Diseases; Humans; Insurance, Health; Japan; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sarcoidosis | 2014 |
Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.
Topics: Biopsy; Fluorodeoxyglucose F18; Glucocorticoids; Heart Diseases; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Prognosis; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
Thorax: normal and benign pathologic patterns in FDG-PET/CT imaging.
Topics: Amyloidosis; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Heart Diseases; Humans; Infections; Lung Diseases; Mediastinal Diseases; Multimodal Imaging; Myocardium; Pleural Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Spinal Diseases; Thoracic Diseases; Thoracic Injuries; Thoracic Vertebrae; Thorax; Tissue Distribution; Tomography, X-Ray Computed | 2014 |
Imaging of the myocardium using (18)F-FDG-PET/MRI.
Topics: Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Integrated anatomy and viability assessment PET-CT.
Topics: Fluorodeoxyglucose F18; Heart Diseases; Humans; Image Interpretation, Computer-Assisted; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Recovery of Function; Tissue Survival; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Fatty acid imaging of the heart.
Topics: Diabetic Cardiomyopathies; Fatty Acids; Fluorodeoxyglucose F18; Heart Diseases; Humans; Myocardial Ischemia; Myocardium; Obesity; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2011 |
Nuclear medicine and molecular imaging of the pediatric chest: current practical imaging assessment.
Topics: Adolescent; Child; Child, Preschool; Fluorodeoxyglucose F18; Gastrointestinal Diseases; Heart; Heart Diseases; Humans; Infant; Iodine Radioisotopes; Lung; Lung Diseases; Lung Neoplasms; Lymphoma; Molecular Imaging; Musculoskeletal Diseases; Myocardial Perfusion Imaging; Nuclear Medicine; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Compounds; Thymus Neoplasms; Tomography, X-Ray Computed; Xenon Radioisotopes | 2011 |
Spectrum of physiological and pathological cardiac and pericardial uptake of FDG in oncology PET-CT.
Topics: Adipose Tissue, Brown; Artifacts; Cardiomyopathies; Fluorodeoxyglucose F18; Heart Atria; Heart Diseases; Heart Ventricles; Humans; Leukemia; Lymphoma; Multimodal Imaging; Myocardium; Organ Specificity; Papillary Muscles; Pericarditis; Pericardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Clinical applications of positron emission tomography in cardiology: a review.
Topics: Coronary Circulation; Exercise Tolerance; Fluorodeoxyglucose F18; Heart Diseases; Humans; Myocardium; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Ventricular Function, Left | 2004 |
Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies.
Topics: Fasting; Fluorodeoxyglucose F18; Heart Diseases; Humans; Incidental Findings; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2007 |
Imaging myocardial metabolism.
Topics: Ascorbic Acid; Fatty Acids; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2007 |
New agents and new techniques in nuclear cardiology.
Topics: Cardiac Output; Coronary Circulation; Coronary Disease; Cost-Benefit Analysis; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Gated Blood-Pool Imaging; Heart Diseases; Humans; Myocardial Contraction; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 1995 |
[Assessment of myocardial energy metabolism with PET].
Topics: Acetic Acid; Carbon Radioisotopes; Deoxyglucose; Energy Metabolism; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Lipid Metabolism; Myocardium; Oxygen Consumption; Palmitic Acid; Tomography, Emission-Computed | 1997 |
Positron emission tomography in cardiovascular disease.
Topics: Coronary Circulation; Coronary Disease; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart Diseases; Heart Transplantation; Humans; Myocardium; Tissue Survival; Tomography, Emission-Computed | 1996 |
[Positron emission tomography of the heart. From research to clinical practice].
Topics: Coronary Circulation; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Myocardial Ischemia; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
[Imaging of myocardial perfusion and metabolism with positron emission tomography].
Topics: Acetates; Ammonia; Animals; Carbon Radioisotopes; Coronary Circulation; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Lipid Metabolism; Models, Biological; Myocardium; Nitrogen Radioisotopes; Oxygen Consumption; Palmitates; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
Topics: Coronary Disease; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Myocardial Revascularization; Myocardium; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2000 |
Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
Topics: Acetates; Carbon Radioisotopes; Fatty Acids; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Myocardium; Oxygen Consumption; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left | 2001 |
51 other study(ies) available for fluorodeoxyglucose f18 and Heart Diseases
| Article | Year |
|---|---|
Cytokine Signaling and Matrix Remodeling Pathways Associated with Cardiac Sarcoidosis Disease Activity Defined Using FDG PET Imaging.
Topics: Aged; Biomarkers; Case-Control Studies; Cytokines; Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Immunosuppressive Agents; Inflammation; Male; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Middle Aged; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Interleukin-2; Receptors, Tumor Necrosis Factor; Risk Assessment; Sarcoidosis; Severity of Illness Index; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2021 |
Previous BioGlue repair mimicking cardiac infection with
Topics: Fluorodeoxyglucose F18; Heart Diseases; Humans; Positron Emission Tomography Computed Tomography; Proteins; Radiopharmaceuticals | 2023 |
Increased cardiac uptake of (
Topics: Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Positron-Emission Tomography; Radiation Injuries; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2022 |
The utility of beta-hydroxybutyrate in detecting myocardial glucose uptake suppression in patients undergoing inflammatory [18F]-FDG PET studies.
Topics: 3-Hydroxybutyric Acid; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
High-Resolution Cardiac Positron Emission Tomography/Computed Tomography for Small Animals.
Topics: Animals; Fluorodeoxyglucose F18; Heart Diseases; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rats; Retrospective Studies | 2022 |
Reappraisal of [18F]FDG-PET/CT for diagnosis and management of cardiac implantable electronic device infections.
Topics: Anti-Bacterial Agents; Defibrillators, Implantable; Fluorodeoxyglucose F18; Heart Diseases; Humans; Pacemaker, Artificial; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Retrospective Studies; Sepsis | 2023 |
The rate of myocardial perfusion recovery after steroid therapy and its implication for cardiac events in cardiac sarcoidosis and primarily preserved left ventricular ejection fraction.
Topics: Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Circulation; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucocorticoids; Heart Diseases; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron Emission Tomography Computed Tomography; Prednisolone; Radiopharmaceuticals; Recovery of Function; Retrospective Studies; Sarcoidosis; Stroke Volume | 2021 |
Myocardial perfusion imaging in cardiac sarcoidosis: A "sine qua non" for prognosis assessment?
Topics: Fluorodeoxyglucose F18; Heart Diseases; Humans; Myocardial Perfusion Imaging; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Sarcoidosis | 2021 |
Left ventricular thrombus on
Topics: Aged; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Thrombosis | 2021 |
Diffuse uptake of [
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Heart; Heart Diseases; Humans; Hypertension; Positron Emission Tomography Computed Tomography | 2022 |
Volume-based glucose metabolic analysis of FDG PET/CT: The optimum threshold and conditions to suppress physiological myocardial uptake.
Topics: Aged; Aorta, Thoracic; Blood Volume; Female; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Male; Middle Aged; Myocardium; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies | 2019 |
Opening the door to noninvasive assessment of cardiac transplant rejection: It's all in the preparation.
Topics: Fluorodeoxyglucose F18; Heart Diseases; Heart Transplantation; Humans; Myocardium; Postoperative Complications | 2020 |
A 1-week extension of a ketogenic diet provides a further decrease in myocardial
Topics: Animal Feed; Animals; Diet, Carbohydrate-Restricted; Diet, Ketogenic; Dietary Carbohydrates; Fasting; Fluorodeoxyglucose F18; Heart; Heart Diseases; Inflammation; Male; Myocarditis; Myocardium; Myosins; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Swine | 2020 |
Focal mass-like cardiac uptake on oncologic FDG PET/CT: Real lesion or atypical pattern of physiologic uptake?
Topics: Adult; Aged; False Positive Reactions; Female; Fluorodeoxyglucose F18; Heart Diseases; Heart Neoplasms; Humans; Image Processing, Computer-Assisted; Lung Neoplasms; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Positron Emission Tomography Computed Tomography; Retrospective Studies | 2019 |
Incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening.
Topics: Aged; Aged, 80 and over; Biological Transport; Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Incidental Findings; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Tomography, X-Ray Computed | 2013 |
Active cardiac sarcoidosis: first clinical experience of simultaneous positron emission tomography--magnetic resonance imaging for the diagnosis of cardiac disease.
Topics: Acute Disease; Aged; Cardiac Imaging Techniques; Female; Fluorodeoxyglucose F18; Gadolinium; Heart Diseases; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2013 |
Clinical utility of a magnetic resonance-conditional pacemaker in a patient with cardiac sarcoidosis.
Topics: Atrioventricular Block; Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Magnetic Resonance Imaging; Middle Aged; Pacemaker, Artificial; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Comment on Minamimoto: incidental focal FDG uptake in heart is a lighthouse for considering cardiac screening.
Topics: Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Incidental Findings; Male; Myocardium | 2013 |
(18)F-FDG-PET CT findings in a patient with early-phase cardiac sarcoidosis.
Topics: Adrenal Cortex Hormones; Atrioventricular Block; Electrocardiography; Fluorodeoxyglucose F18; Heart Diseases; Humans; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis.
Topics: Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed | 2014 |
Quantifying myocardial inflammation using F18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis.
Topics: Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Image Interpretation, Computer-Assisted; Male; Myocardial Perfusion Imaging; Positron-Emission Tomography; Sarcoidosis; Tomography, X-Ray Computed | 2014 |
Administration of unfractionated heparin with prolonged fasting could reduce physiological 18F-fluorodeoxyglucose uptake in the heart.
Topics: Biomarkers; Contrast Media; Fasting; Female; Fluorodeoxyglucose F18; Heart Diseases; Heparin; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Time Factors | 2016 |
Quantifying FDG uptake to diagnose cardiac device infections: When and how should we do it?
Topics: Fluorodeoxyglucose F18; Heart Diseases; Humans; Positron-Emission Tomography; Radiopharmaceuticals | 2016 |
Cardiac Sarcoidosis Detected by (18)F-Fluorodeoxyglucose Positron Emission Tomography.
Topics: Cardiomyopathy, Dilated; Fluorodeoxyglucose F18; Heart Diseases; Humans; Lymphadenopathy; Magnetic Resonance Imaging; Male; Mediastinum; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2016 |
Appropriate indications for positron emission tomography/computed tomography: College of Nuclear Physicians of the Colleges of Medicine of South Africa.
Topics: Fluorodeoxyglucose F18; Heart Diseases; Humans; Infections; Inflammation; Neoplasms; Nervous System Diseases; Positron-Emission Tomography; South Africa; Tomography, X-Ray Computed | 2015 |
Multimodality Diagnosis Approach of Cardiac Aspergillosis.
Topics: Aspergillosis; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Diseases; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2016 |
Differentiation of cardiac thrombus from cardiac tumor combining cardiac MRI and 18F-FDG-PET/CT Imaging.
Topics: Aged; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Diseases; Heart Neoplasms; Humans; Magnetic Resonance Imaging, Cine; Male; Positron Emission Tomography Computed Tomography; Thrombosis | 2016 |
High intraindividual variability of global myocardial 18F-FDG uptake over time.
Topics: Fasting; Female; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Myocardium; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Fluorodeoxyglucose-positron emission tomography differentiating thrombus from tumor in the left ventricle.
Topics: Bronchial Neoplasms; Carcinoma; Diagnosis, Differential; Fluorodeoxyglucose F18; Heart Diseases; Heart Neoplasms; Heart Ventricles; Humans; Positron-Emission Tomography; Thrombosis | 2009 |
Myocardial metastasis or benign brown fat?
Topics: Adipose Tissue, Brown; Diagnostic Errors; Echocardiography, Transesophageal; Female; Fluorodeoxyglucose F18; Heart Diseases; Heart Neoplasms; Humans; Lipomatosis; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2009 |
In vivo assessment of myocardial glucose uptake by positron emission tomography in adults with the PRKAG2 cardiac syndrome.
Topics: Adult; AMP-Activated Protein Kinases; Case-Control Studies; Echocardiography; Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Male; Metabolic Diseases; Middle Aged; Mutation; Myocardium; Phenotype; Radiographic Image Interpretation, Computer-Assisted; Rubidium Radioisotopes; Statistics, Nonparametric; Syndrome; Tomography, Emission-Computed | 2009 |
Images in cardiovascular medicine: Imaging of cardiac sarcoid lesions using fasting cardiac 18F-fluorodeoxyglucose positron emission tomography: an autopsy case.
Topics: Fatal Outcome; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Male; Middle Aged; Papillary Muscles; Positron-Emission Tomography; Sarcoidosis | 2010 |
Variable cardiac 18FDG patterns seen in oncologic positron emission tomography computed tomography: importance for differentiating normal physiology from cardiac and paracardiac disease.
Topics: Adult; Female; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Thoracic Neoplasms; Tomography, X-Ray Computed; Young Adult | 2012 |
Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients.
Topics: Adult; Churg-Strauss Syndrome; Diagnosis, Differential; Female; Fibrosis; Fluorodeoxyglucose F18; Heart Diseases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Remission Induction | 2013 |
Delineation of the cardiac substructures based on PET-CT and contrast-enhanced CT in patients with left breast cancer treated with postoperative radiotherapy.
Topics: Adult; Aged; Breast Neoplasms; Cardiac Volume; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Heart Diseases; Heart Ventricles; Humans; Middle Aged; Pilot Projects; Postoperative Period; Radiation Injuries; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Stroke Volume | 2013 |
Journey in evolution of nuclear cardiology: will there be another quantum leap with the F-18-labeled myocardial perfusion tracers?
Topics: Cardiology; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart Diseases; History, 20th Century; History, 21st Century; Humans; Myocardial Perfusion Imaging; Nuclear Medicine; Radioactive Tracers | 2012 |
2-[¹⁸F]fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography (PET) findings of chronic expanding intrapericardial hematoma: a potential interpretive pitfall that mimics a malignant tumor.
Topics: Aged; Fluorodeoxyglucose F18; Heart Diseases; Hematoma; Humans; Male; Pericardium; Positron-Emission Tomography; Radiopharmaceuticals | 2013 |
Increased FDG uptake in the right cardiac chambers in a patient with pulmonary emphysema.
Topics: Adenocarcinoma; Fluorodeoxyglucose F18; Heart Diseases; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Lung Neoplasms; Male; Middle Aged; Pulmonary Emphysema; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: against.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Heart Diseases; Humans; Image Processing, Computer-Assisted; Ischemia; Myocardium; Perfusion; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2005 |
FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: for.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Heart Diseases; Humans; Image Processing, Computer-Assisted; Myocardium; Perfusion; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Sensitivity and Specificity | 2005 |
PET/CT quantitation of the effect of patient-related factors on cardiac 18F-FDG uptake.
Topics: Adult; Aged; Aged, 80 and over; Aging; Benzodiazepines; Bezafibrate; Diabetes Mellitus; Drug Interactions; Female; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Hypolipidemic Agents; Male; Middle Aged; Multivariate Analysis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Thyroxine; Tomography, X-Ray Computed; Whole-Body Counting | 2007 |
Spatial and temporal heterogeneity of regional myocardial uptake in patients without heart disease under fasting conditions on repeated whole-body 18F-FDG PET/CT.
Topics: Fasting; Female; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Image Interpretation, Computer-Assisted; Male; Metabolic Clearance Rate; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution; Tomography, X-Ray Computed; Whole Body Imaging | 2007 |
Simplified PET quantitation of myocardial glucose utilization.
Topics: Animals; Blood Glucose; Brain; Carbon Radioisotopes; Deoxyglucose; Feasibility Studies; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Heart; Heart Diseases; Humans; Male; Muscle, Skeletal; Myocardium; Rats; Rats, Wistar; Reference Values; Reproducibility of Results; Tomography, Emission-Computed | 1995 |
Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization.
Topics: Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Prognosis; Survival Analysis; Ventricular Dysfunction, Left | 1994 |
Differentiation of cardiac tumor from thrombus by combined MRI and F-18 FDG PET imaging.
Topics: Adult; Breast Neoplasms; Carcinoma; Diagnosis, Differential; Echocardiography; Female; Fluorodeoxyglucose F18; Heart Diseases; Heart Neoplasms; Humans; Magnetic Resonance Imaging; Radiopharmaceuticals; Thrombosis; Tomography, Emission-Computed | 1998 |
Predictive value of planar 18F-fluorodeoxyglucose imaging for cardiac events in patients after acute myocardial infarction.
Topics: Aged; Cardiac Catheterization; Echo-Planar Imaging; Feasibility Studies; Female; Fluorodeoxyglucose F18; Heart Diseases; Humans; Logistic Models; Male; Middle Aged; Myocardial Infarction; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Thallium Radioisotopes | 1998 |
Nuclear medicine: the road to smart medicine and surgery.
Topics: Brain Diseases; Colorectal Neoplasms; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Heart Diseases; Humans; Lung Neoplasms; Nuclear Medicine; Radionuclide Imaging; Radiopharmaceuticals; Stomach Neoplasms; Thyroid Diseases | 1998 |
Costs of F-18-FDG PET: experience with a satellite concept.
Topics: Brain; Brain Diseases; Costs and Cost Analysis; Fluorodeoxyglucose F18; Germany; Heart; Heart Diseases; Humans; Models, Theoretical; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Enhanced myocardial glucose use in patients with a deficiency in long-chain fatty acid transport (CD36 deficiency).
Topics: Aged; Blood Platelets; Carrier Proteins; CD36 Antigens; Fatty Acids; Female; Flow Cytometry; Fluorodeoxyglucose F18; Glucose; Heart; Heart Diseases; Humans; Iodobenzenes; Male; Middle Aged; Monocytes; Myocardium; Radiopharmaceuticals; Thallium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1999 |
[PET assessment of myocardial viability with glucose loading and fasting FDG images].
Topics: Adult; Aged; Deoxy Sugars; Deoxyglucose; Fasting; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Heart Diseases; Humans; Male; Middle Aged; Myocardium; Tomography, Emission-Computed | 1990 |
Emission tomography and cardiac nuclear medicine.
Topics: Deoxyglucose; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Image Processing, Computer-Assisted; Myocardial Infarction; Radioisotopes; Technetium; Technetium Tc 99m Pyrophosphate; Thallium; Tin Polyphosphates; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1986 |